Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Fluticasone Furoate on HPA Axis in Children with PAR
NCT00116883Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in perennial allergic rhinitis (PAR) comparing GW685698X with Placebo (2 arms). Primary endpoint: Hypothalamic Pituitary Adrenocortical Axis Function at 6 weeks. Started Feb 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00116883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116883.